[ Price : $8.95]
Federal Register notice: FDA announces a 3/30 public meeting entitled Patient-Focused Drug Development for Vitiligo.[ Price : $8.95]
FDA announces a 4/20-21 workshop entitled The 12th Annual Sentinel Initiative Public Workshop.[ Price : $8.95]
Trevena resubmits its NDA for oliceridine for managing moderate-to-severe acute pain.[ Price : $8.95]
Pfizer and Astellas Pharma report study data demonstrating a statistically significant improvement in overall survival in men with...[ Price : $8.95]
FDA releases its latest batch of Warning Letters that includes one medical product company Marco Pharma.[ Price : $8.95]
FDA and BrainStorm Cell Therapeutics agree on a potential regulatory approval path for NurOwn to treat ALS.[ Price : $8.95]
FDA puts a clinical hold on LogicBio Therapeutics LB-001 IND being investigated to treat methylmalonic acidemia.[ Price : $8.95]
Washington Legal Foundation asks the 9th Circuit Court of Appeals to enjoin a California law that presumes most drug patent settle...